Literature DB >> 12066781

Control of myocardial oxygen consumption: relative influence of contractile state and tension development.

T P Graham, J W Covell, E H Sonnenblick, J Ross, E Braunwald.   

Abstract

Myocardial oxygen consumption was measured in 11 anesthetized, open-chest dogs in order to compare in the same heart the relative influence on oxygen usage of tension development and the contractile or inotropic state, as reflected in V(max.) the maximum velocity of shortening of the unloaded contractile elements. The isovolumetrically contracting left ventricle was studied with left ventricular volume, heart rate, and systemic perfusion rate controlled. Wall tension, contractile element velocity, and V(max) were calculated. Peak developed tension was increased at a constant V(max) by increasing ventricular volume, and the effect on oxygen consumption was determined. Oxygen utilization was then redetermined at an increased V(max) but at a constant peak developed tension by infusing norepinephrine (0.76 to 7.6 mug/min) and decreasing ventricular volume to match the tension existing before norepinephrine infusion. Oxygen consumption consistently increased with increases in both developed tension and V(max) with the following multiple regression equation relating these variables: myocardial oxygen consumption (mul/beat per 100 g in LV) = K + 0.25 peak developed tension (g/cm(2)) + 1.43 V(max) (cm/sec). These data indicate that the oxygen cost of augmentation of contractility is substantial, can be independent of any change in fiber shortening, and is similar in order of magnitude to the effect of alterations in tension development

Entities:  

Mesh:

Year:  1968        PMID: 12066781      PMCID: PMC297180          DOI: 10.1172/JCI105734

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE.

Authors:  N KRASNOW; E L ROLETT; P M YURCHAK; W B HOOD; R GORLIN
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  LEFT VENTRICULAR VOLUME IN MAN MEASURED BY THERMODILUTION.

Authors:  R GORLIN; E L ROLETT; P M YURCHAK; W C ELLIOTT
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

3.  MYOCARDIAL OXYGEN CONSUMPTION DURING VENTRICULAR CONTRACTION AND RELAXATION.

Authors:  R G MONROE
Journal:  Circ Res       Date:  1964-04       Impact factor: 17.367

4.  Ventricular pressure-volume relationships and oxygen consumption in fibrillation and arrest.

Authors:  R G MONROE; G FRENCH
Journal:  Circ Res       Date:  1960-01       Impact factor: 17.367

5.  Oxygen uptake of the nonworking left ventricle.

Authors:  W P McKEEVER; D E GREGG; P C CANNEY
Journal:  Circ Res       Date:  1958-09       Impact factor: 17.367

6.  Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

Authors:  S J Sarnoff; E Braunwald; G H Welch; R B Case; W N Stainsby; R Macruz
Journal:  Am J Physiol       Date:  1958-01

7.  Mechanism of increase of myocardial oxygen uptake produced by catecholamines.

Authors:  F J Klocke; G A Kaiser; J Ross; E Braunwald
Journal:  Am J Physiol       Date:  1965-11

8.  Inotropic augmentation of myocardial oxygen consumption.

Authors:  R L Clancy; T P Graham; W J Powell; J P Gilmore
Journal:  Am J Physiol       Date:  1967-05

9.  Heat production in a cardiac contraction.

Authors:  N V Ricchiuti; C L Gibbs
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

10.  Activation heat in frog sartorius muscle.

Authors:  C L Gibbs; N V Ricchiuti; W F Mommaerts
Journal:  J Gen Physiol       Date:  1966-01       Impact factor: 4.086

View more
  49 in total

Review 1.  The pathophysiology of myocardial ischaemia.

Authors:  David C Crossman
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

2.  Series elasticity in the intact heart. Evidence for the application of the Hill model for muscle to the intact left ventricle.

Authors:  J W Covell; R R Taylor; E H Sonnenblick; J Ross
Journal:  Pflugers Arch       Date:  1975-06-26       Impact factor: 3.657

3.  Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria.

Authors:  Peter J Hanley; John Ray; Ulrich Brandt; Jürgen Daut
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

4.  Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.

Authors:  H Pouleur; C van Eyll; J Etienne; H van Mechelen; A Vuylsteke; M F Rousseau
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

5.  Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.

Authors:  Marvin W Kronenberg; Gerald I Cohen; Marlo F Leonen; Thomas A Mladsi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

6.  The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.

Authors:  K C Lasseter; G S Levey; R F Palmer; J S McCarthy
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  The oxygen consumption paradox of "stunned myocardium" in dogs.

Authors:  E N Dean; M Shlafer; J M Nicklas
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

8.  Experimental myocardial infarction. 8. Chronotropic augmentation of cardiac function in left ventricular failure of acute and healing stages in intact conscious dogs.

Authors:  R Kumar; J Joison; D P Gilmour; F A Molokhia; C A Pegg; W B Hood
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

9.  Myocardial oxygen consumption and regulation of coronary blood flow during stepped relief of the left ventricle.

Authors:  W Steven; H Nier; R Jaeschock; R Schultheis; R Neuhaus; G Arnold
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

10.  Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.

Authors:  H DeMots; S H Rahimtoola; E L Kremkau; W Bennett; D Mahler
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.